The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress
Author(s) -
Antônio RibeiroOliveira,
Mirna Bastos Marques,
Walkíria Wingester Vilas-Boas,
J. Afonso Guimarães,
Cândido Celso Coimbra,
Allan P. Anjos,
Rodrigo Bastos Fóscolo,
Robson A.S. Santos,
Julia Thomas,
Susana Igreja,
Blerina Kola,
Ashley Grossman,
Márta Korbonits
Publication year - 2013
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320313499199
Subject(s) - candesartan , ampk , protein kinase a , medicine , adenosine , endocrinology , adenosine monophosphate , cyclic adenosine monophosphate , amp activated protein kinase , surgical stress , angiotensin ii , kinase , receptor , chemistry , biochemistry
adenosine monophosphate-activated protein kinase (AMPK) plays a prominent role as a metabolic stress sensor, and it has recently been suggested that the renin-angiotensin system, in addition to its role in stress regulation, may play a significant role in regulating the AMPK system. This study aimed to evaluate the effects of candesartan, an angiotensin II receptor blocker, on cardiac and hepatic AMPK activity basally as well as after surgical stress under general anesthesia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom